NYSE ARCA | ETF
The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index.
The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies" products and services.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.54% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 2.38% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.33% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 2.32% |
| IRTC | iRhythm Technologies Inc | Healthcare | Medical Devices | 2.23% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.18% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.12% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.05% |
| ERF | Eurofins Scientific SE | Healthcare | Diagnostics & Research | 2.05% |
| AORT | Artivion Inc | Healthcare | Medical Devices | 2.02% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 1.98% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 1.95% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 1.91% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.90% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.87% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 1.85% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 1.84% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 1.82% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.78% |
| PKI | PerkinElmer Inc | Healthcare | Diagnostics & Research | 1.77% |